Mass Media
2024
- The President of Active Component shared his opinion on the difficulties observed by pharmaceutical manufacturers in making payments and receiving supplies from China
Source: Telegram channel "Right to health", 28.05.2024 - Drug independence
Source: Expert, 29.05.2024 - The Ministry of Finance of the Russian Federation plans to introduce an excise tax on medical alcohol and alcohol-containing medicines
Source: Vedomosti, 28.05.2024 - The country's pharmaceutical industry works to preserve and enhance the health of Russians
Source: Russian newspaper, 24.05.2024 - Member of “Business Russia”: which drugs are not yet produced in Russia
Source: Information agency URA.RU, 03.02.2024 - Actiсomp received a loan of almost 3 billion rubles from the state to expand the production of pharmaceutical substances
Source: "Pharmmed", 31.01.2024 - Acticomp launches construction of new laboratory and production facilities
Source: "Pharmprom", 31.01.2024 - A pharmaceutical company will receive a preferential loan to organize import-substituting production
Source: "TT Finance", 29.01.2024 - Acticomp was approved for a preferential loan of 2.9 billion RUR for production
Source: "Pharmaceutical Bulletin", 29.01.2024 - Special report "Just what the doctor ordered"
Source: TV channel "Russia 24", 10.01.2024 - Results of the year. Tablet for optimism
Source: "New Prospect", 05.01.2024
2023
- Alexander Semenov: “The Central Bank’s increase in the rate by more than two times this year did not contribute to business growth”
Source: "Monocle", 28.12.2023 - Medicines and medical products are exempt from duties
Source: "Monocle", 25.12.2023 - There is growth. There will be growth!
Source: "Monocle", 25.12.2023 - Rating of top managers according to Kommersant-SPb. Industries "Pharmaceutical industry" and "Private medicine"
Source: Newspaper "Kommersant-SPb", 19.12.2023 - Should research on Western drugs be canceled in Russia?
Source: Moskovskaya Gazeta, 16.11.2023 - Reduces consequences
Source: Pharmaceutical Bulletin, 14.11.2023 - According to the image and standard
Source: Pharmaceutical Bulletin, 07.11.2023 - Indian quality and quantity: how many medicines from the “country of Bharat” are in Russian pharmacies?
Source: Moskovskaya Gazeta, 01.11.2023 - Promotions on rubbing alcohol may include the cost of certain medications
Source: Moskovskaya Gazeta, 27.10.2023 - Pharmaceutical takeoff: drug production is growing in St. Petersburg
Source: Evening St. Petersburg, 02.10.2023 - 29 St. Petersburg residents won the final of the fifth “Leaders of Russia” competition in the Northwestern Federal District
Source: Evening St. Petersburg, 25.09.2023 - The names of 37 winners of the district final of the fifth competition "Leaders of Russia" in the Northwestern Federal District have been announced
Source: RAPSI, 25.09.2023 - Pharmaceutical substances will be checked for nationality
Source: Kommersant, 18.09.2023 - There are benefits, but they are not that significant
Source: Kommersant, 08.09.2023 - Prices for vital medicines may rise in Russia
Source: Moscow 24 TV channel, 04.08.2023 - Russia-Africa: cooperation in the field of healthcare
Source: Pharmmedprom, 04.08.2023 - Pharmaceutical associations suggest that they will not impose an excise tax on ethanol in order to avoid a rise in prices in pharmacies
Source: Vedomosti, 03.08.2023 - Alexander Semyonov: "Production should include at least one stage of chemical synthesis"
Source: Katren Style, 27.07.2023 - The pharmaceutical industry is heading back
Source: Expert, 17.07.2023 - The necessary steps for the production of pharmaceutical substances from scratch will be discussed at the RSPP site
Source: Pharmaceutical Bulletin, 12.07.2023 - Substance Caretakers
Source: Kommersant, 12.07.2023 - Alexander Semenov: "If Russian pharmaceuticals are teenagers, then European pharmaceuticals in the field of production of substances are children in general"
Source: Pharmaceutical Bulletin, 11.07.2023 - Substances get better on dietary supplements
Source: Kommersant, 29.06.2023 - Pharma-2030 is a chance for further development of domestic pharmaceuticals in the interests of patients
Source: Pharmedu.ru, 20.06.2023 - Heads of pharmaceutical companies commented on the approval of the Strategy for the Development of the Pharmaceutical Industry of the Russian Federation until 2030
Source: Pharmmedprom.ru, 20.06.2023 - Pharmaceutical manufacturers urged to launch a traceability system for the origin of substances
Source: Farmedinstvo.info, 20.06.2023 - The system for tracking the origin of pharmaceutical substances was proposed to be introduced in Russia
Source: GxP News, 20.06.2023 - Pharmaceutical manufacturers urged to launch a traceability system for the origin of substances
Source: TASS, 19.06.2023 - Pharmaceutical company revealed the reasons for the shortage of drugs in Russia
Source: Radio1.news, 27.01.2023
2022
- Top managers range in the «Pharmaceutical industry» nomination
Source: Kommersant, 22.12.2022 - XIV Russian Congress of Pharmaceutical and Medical Industry Workers
Source: Rspp.ru, 06.12.2022 - Crocus Expo hosts the leading international exhibition Pharmtech & Ingredients
Source: Inpharm.ru, 01.11.2022 - Associative approach: how do pharmaceutical manufacturers' organizations work
Source: Pharmmedprom, 19.10.2022 - Homo SAPiens: how Russian business is getting rid of foreign software
Source: RBC+, 05.10.2022 - Samples of the fatherland: Medicines will be manufactured according to Russian standards
Source: Kommersant, 23.09.2022 - APMEEU proposed to introduce the origin traceability system for pharmaceutical substances
Source: Pharmaceutical Bulletin, 19.09.2022 - «Eurasians» stand for integration in the field of good manufacturing practices
Source: Pharmjournal.ru, 12.09.2022 - The Indian Way: what does the concept of «medicinal sovereignty» mean for the Russian Federation
Source: NEWS.ru, 10.08.2022 - Alexander Semenov told what kind of government support will help strengthen the domestic pharma
Source: RBC, 16.06.2022 - The united EAEU pharmaceutical market is ready for new challenges
Source: RIA Standards and quality, 04.04.2022 - Alexander Semyonov: «Russian pharmaceutical companies can fill up to 90% of the market, but they need support»
Source: New avenue, 01.04.2022 - «Perfect Storm» — a test of business strength
Source: RBC+, 25.03.2022 - Development of the Russian institute of Standardized Materials as a minimum program
Source: Kommersant, 10.03.2022 - The State Government discussed ways to support pharmaceutical business in the new economic conditions
Source: Pharmaceutical Bulletin, 28.02.2022 - Alexander Semyonov: Focus on the domestic market and independence
Source: News24.pro, 07.01.2022
2021
- Expert opinion on the future of Russian production of pharmaceutical substances
Source: PharmProm.rf, 26.11.2021 - Strategy of the Russian pharmaceutical industry development «Pharma 2030»
Source: News-Life, 06.11.2021 - Experts discussed the future of healthcare
Source: Russian newspaper, 12.10.2021 - Inna Semyonova entered the TOP100 list of successful women in pharmaceutical industry
Source: Russian Pharmaceutics, 27.09.2021 - The expert explained how the pandemic affected the pharmaceutical market of St. Petersburg
Source: Nevskiye Novosti, 21.05.2021 - Foreign manufacturers criticized the discussion of the "second superfluous" behind "closed doors"
Source: Pharmaceutical Bulletin, 12.05.2021 - "Active Component" summed up the results of the year
Source: Pharmmedprom, 28.04.2021 - Winners among pharmacists. The results of the Platinum Ounce competition have been summed up
Source: Arguments and Facts, 26.04.2021 - Russian Government is Changing the Market for Manufacture of Important Drugs: Expert Explains
Source: FederalPress, 22.04.2021 - Ministry of Industry and Trade Proposes to Limit Purchase of Drugs Made of Non-Russian Substances
Source: Pharmaceutical Bulletin, 16.03.2021 - Expert: Only 6% of Substances for Manufacture of Strategically Important Drugs are Produced in Russia
Source: TASS, 06.02.2021
2020
- Investors Were Prescribed Drugs. Smolny Intends to Purchase Drugs under Offset Contracts
Source: Fontanka, 17.12.2020 - The Best Top Managers of Pharmaceutical Industry and Private Medicine were Identified in Saint Petersburg
Source: Kommersant, 17.12.2020 - Alexander Semenov: Low Drug Prices Provoke their Shortage
Source: New avenue, 16.12.2020 - Representatives of Pharmaceutical Companies Explained Development Trends of the Industry for the Next Decade.
Source: Remedium, 25.10.2020 - For the First Time in Russia Special Investment Contract Was Executed With a Manufacturer of Pharmaceutical Substances
Source: Minpromtorg, 22.10.2020 - Russian Active Pharmaceutical Ingredients Have a Large Assurance Coefficient
Source: GxP News, 08.10.2020 - Russia Began to Produce more Pharmaceutical Substances, but their Amount is still Insufficient
Source: Pharmmedprom.ru, 01.10.2020 - Active Component and Pharmacor Production will Receive Loans for Production Development
Source: GxP News, 15.09.2020 - Active Component Signed an Agreement with the National Center for Reference Materials
Source: Kommersant, 27.08.2020 - Trade Representation In Norway Held A Meeting With A Russian Pharmaceutical Company
Source: Minpromtorg, 05.08.2020 - Image Focus: How Private Medicine Makes Money out of Fear of COVID-19
Source: DP.ru, 19.07.2020 - Active Component Registered a German COVID-19 Antibodies Rapid Test in Russia
Source: GxP News, 29.06.2020 - Russian Pharmaceutical Companies Warned About Increase in Price
Source: Vedomosti, 29.04.2020 - Active Component will be Engaged in Full Cycle Production of Remdesivir
Source: Pharmaceutical Bulletin, 14.04.2020 - Active Component Increased Revenue by 43% in 2019
Source: «Pharmaceutical Bulletin», 08.04.2020 - "Generium" and "Active Component" will be able to conclude a SPIC according to the old rules
Source: Vademecum, 08.04.2020 - Saint Petersburg Authorities Proposed Benefits for Companies Under Special Investment Contracts due to the Pandemic
Source: TASS, 27.03.2020 - Manufacturers Proposed to Create a Reserve of Necessary Pharmaceutical Substances Under the Federal State Reserve Agency
Source: Pharmaceutical Bulletin, 10.03.2020 - Saint Petersburg Pharmaceutical Manufacturers May Face a Shortage of Raw Materials
Source: Kommersant, 26.02.2020 - Manufacturers Predict Shortage of Pharmaceutical Substances due to Coronavirus
Source: Pharmaceutical Bulletin, 19.02.2020
2019
- Initiatives Were Developed to Stimulate Investment in Pharmaceutical Substances Production
Source: Pharmaceutical Bulletin, 28.10.2019 - "Active Component" Intends to Begin Deliveries of Its Pharmaceutical Substances to Cuba in 2020
Source: Interfax-Russia, 27.09.2019 - Ministry of Industry and Trade of the Russian Federation Approved a Draft Special Investment Contract of "Active Component"
Source: Kommersant, 08.08.2019 - Pharmaceutical Engineering Market Needs Smart Regulation
Source: Pharmaceutical Bulletin, 26.06.2019 - "Active Component" Confirmed Its Local Manufacturer Status for 19 Pharmaceutical Substances
Source: Kommersant, 28.05.2019 - "Active Component" has applied for a SPIC for 2.5 billion rubles
Source: Vademecum, 21.05.2019 - "Active Component" Intends to Start Optimization
Source: Kommersant, 23.04.2019 - Russian Companies are Eager to Develop Their Export Potential, but Face the Hinder of Labeling Costs
Source: Pharmaceutical Bulletin, 03.04.2019 - "Active Component" Received Local Status Confirmation for Nineteen Products
Source: Pharmaceutical Bulletin, 19.03.2019 - "Active Component" Company Increased the Amount of Pharmaceutical Production by 15%
Source: Kommersant, 27.02.2019
2018
- Saint Petersburg Became a Pharmaceutical Capital of Russia
Source: St. Petersburg Vedomosti, 11.12.2018 - Russian Pharmaceutical Industry is Ready for Global Competition
Source: Pharmaceutical Bulletin, 19.11.2018 - Active Component Attracted a Minority Financial Investor to the Company
Source: Pharmaceutical Bulletin, 03.09.2018 - Elbrus Capital Investment Foundation Got a Minority Stake in the Active Component Pharmaceutical Company
Source: Vc.ru, 03.09.2018 - Expert: Chinese Factor in Pharmaceutical Substances Production will Greatly Affect the Russian Market
Source: Pharmaceutical Bulletin, 30.03.2018 - The Active Component Company Supplied more than 50 tons of Pharmaceutical Substances to the Market
Source: advis.ru, 27.02.2018 - Saint Petersburg Company Active Component Supplied 55 tons of Pharmaceutical Substances to the Market in 2017
Source: Kommersant, 26.02.2018 - Glatt German Company will Design "Active Component" Plant Worth 2 Billion Rubles Near Saint Petersburg
Source: Interfax-Russia, 13.02.2018
2017
- A third of medicines may disappear from pharmacies
Source: RBC, 23.06.2017 - The Active Component company will build a new plant by 2020
Source: DEGA MARKET, 22.06.2017 - Modernization has been completed and the production of substances has been increased by 1.5 times — Active Component Company
Source: Lekoboz, 22.06.2017 - Russian drug manufacturers began to crowd competitors
Source: Russian newspaper, 21.06.2017 - 300 Million Rubles Into Medicines
Source: Vedomosti, 21.06.2017 - The "active component" increased the volume of production of substances by 1.5 times
Source: Kommersant, 19.06.2017 - "Active Component" will build a new plant by 2020
Source: Advis.ru, 09.06.2017 - A pharmaceutical factory is being sold in St. Petersburg
Source: RBC, 07.06.2017 - Import substitution is not a goal, but a means
Source: Kp.ru, 05.06.2017 - "Active component" intends to increase the export of pharmaceutical substances to 1.5 billion rubles
Source: Recipe.ru, 05.06.2017 - "Active Component" will build a new plant by 2020
Source: Pharmaceutical Bulletin, 05.06.2017 - "Active Component" will build a new plant by 2020
Source: Russian Pharmaceutics, 05.06.2017 - It will take at least 5 years to enter the European market
Source: GxP News, 02.06.2017 - Several pharmaceutical factories will appear near St. Petersburg at once
Source: RBC, 02.06.2017 - "Active Component" invests 2 billion rubles in the creation of the life-science park
Source: GxP News, 02.06.2017 - "Active Component" will build a new plant by 2020
Source: Recipe.ru, 05.06.2017 - What was agreed at SPIEF 2017. St. Petersburg Agenda
Source: TV channel "Saint Petersburg, 03.06.2017 - The investments of MSD and R-Pharm in the localization of raltegravir amounted to 200 million rubles
Source: GxP News, 02.06.2017 - "Active component" plans to increase the export of pharmaceutical substances to 1.5 billion rubles by 2020
Source: PRIME, 02.06.2017 - "Active Component" invests 2 billion rubles in the creation of the life-science park
Source: Russian Pharmaceutics, 02.06.2017 - SPIEF-2017: signed an agreement of intent between St. Petersburg and JSC "Active Component"
Source: Investment portal of St. Petersburg, 02.06.2017 - St. Petersburg signed agreements for almost 250 billion rubles at the SPIEF
Source: Petersburg Diary, 02.06.2017 - Petersburg signed an agreement for 250 billion rubles at the SPIEF
Source: Gorodskoyportal.ru, 02.06.2017 - The work of Russian pharmaceutical manufacturers abroad will spur the growth of the country's economy
Source: Gfaclaims.com, 02.06.2017 - The work of Russian pharmaceutical manufacturers abroad will spur the growth of the country's economy
Source: Lenta.Ru, 02.06.2017 - Another 8.5 billion rubles will be invested in the medical and pharmaceutical cluster of St. Petersburg
Source: Advis.ru, 02.06.2017 - Another 8.5 billion rubles will be invested in the medical and pharmaceutical cluster of St. Petersburg
Source: Fontanka, 02.06.2017 - The work of Russian pharmaceutical manufacturers abroad will spur the growth of the country's economy
Source: Last24, 02.06.2017 - "Acticomp" plans to invest 2 billion rubles in the production of pharmaceutical substances
Source: News@Rambler.ru, 02.06.2017 - "Acticomp" plans to invest 2 billion rubles in the production of pharmaceutical substances
Source: Kommersant, 02.06.2017 - “There are not enough specialists in all segments in the field of drug circulation”
Source: Kommersant, 02.06.2017 - “Acticomp” will increase the share of exports by 6 times
Source: Dp.ru, 01.06.2017 - The pharmaceutical company "Active Component" bought DSK "Slavyansky" for 400 million rubles
Source: Mergers.ru, 23.05.2017 - In Russia, localized pharmaceutical products were produced for 90 billion rubles
Source: Lekoboz, 23.05.2017 - There are many myths in the Russian pharmaceutical market
Source: Moscow pharmacies, 22.05.2017 - St. Petersburg employers are doomed to invest in students
Source: RBC, 19.05.2017 - The Russian Ministry of Industry and Trade outlined the main legislative initiatives in the pharmaceutical industry
Source: Advis.ru, 19.05.2017 - St. Petersburg in five minutes: thin ice near Isaac and demolitions on Krestovsky
Source: RBC, 15.05.2017 - Oleg Zherebtsov's Solopharm pharmaceutical plant will produce thermal water, lotions and shampoos
Source: Dp.ru, 15.05.2017